AVEO Oncology
AVEO
#5982
Rank
$0.52 B
Marketcap
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)

P/E ratio for AVEO Oncology (AVEO)

P/E ratio as of March 2024 (TTM): -17.9

According to AVEO Oncology 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -17.8571. At the end of 2021 the company had a P/E ratio of -2.73.

P/E ratio history for AVEO Oncology from 2010 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-2.73-19.19%
2020-3.37-133.51%
201910.1-131.47%
2018-32.0599.64%
2017-4.57238.8%
2016-1.35
2014-0.8237
2012-3.06

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
143-902.42%๐Ÿ‡บ๐Ÿ‡ธ USA
20.1-212.52%๐Ÿ‡บ๐Ÿ‡ธ USA
11.7-165.41%๐Ÿ‡บ๐Ÿ‡ธ USA
25.8-244.27%๐Ÿ‡บ๐Ÿ‡ธ USA
13.7-176.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-134 651.93%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.